Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in Hepatitis C
NCT00189163Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Jan 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hepatitis C virus infection comparing Pioglitazone Arm with Placebo Arm (2 arms). Primary endpoint: Virologic Response at 72 weeks. Started Jan 2005; status: completed.
02
Drugs
pioglitazone
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00189163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189163.